Safety and Activity of the Highly Specific BTK Inhibitor BGB-3111 in Combination with the PD-1 Inhibitor BGB-A317 in Patients with B-Cell Lymphoid Malignancies
暂无分享,去创建一个
C. Tam | Xiaoping Zhang | J. Trotman | S. Ro | S. Feng | Jane E. Huang | J. Hilger | G. Cull | Stephen Samuel Opat